• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

In the New Edition of 'Disease and Therapy Review', Diagnosis of Neuropathic Pain is Covered As Well As Information on Treatment Options Approved By the FDA for the Treatment of Neuropathic Pain

Posted on: Thursday, 10 May 2007, 09:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c56488) has announced the addition of Disease and Therapy Review: Neuropathic Pain to their offering.

The Neuropathic Pain Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries, as available worldwide. Information specific to diabetic neuropathies and postherpetic neuralgia are covered in-depth. Other types of neuropathic pain, such as neuropathic pain associated with HIV/AIDS are also discussed. Diagnosis of neuropathic pain is covered, along with information on treatment options approved by the FDA for the treatment of neuropathic pain. Dosing for commonly used medications is provided, along with treatment costs of FDA approved neuropathic pain medications. Market size estimates and annual sales of leading therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by a senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

Content Outline:

I. OVERVIEW

General Overview

Diabetic Neuropathies

Postherpetic Neuralgia

II. INCIDENCE AND PREVALENCE

Incidence Table: (UK))

Prevalence Table: (US)

General incidence and prevalence notes for diabetic neuropathic pain

General incidence and prevalence notes for neuropathic pain associated with HIV/AIDS

III. DIAGNOSIS

IV. TREATMENT

Overview

Postherpetic Neuralgia

Diabetic Peripheral Neuropathic Pain

V. DOSING AND TREATMENT COSTS

Table: Dosing of commonly used medications in the treatment of neuropathic pain

Table: FDA approved neuropathic pain medications -- cost of therapy

VI. MARKET SIZE

VII. COMMENTS

VIII. REFERENCES/RESOURCES

For more information visit http://www.researchandmarkets.com/reports/c56488

Source: Business Wire

More News in this Category